GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » EBITDA Margin %

FDC (NSE:FDC) EBITDA Margin % : 20.41% (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is FDC EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. FDC's EBITDA for the three months ended in Sep. 2024 was ₹1,049 Mil. FDC's Revenue for the three months ended in Sep. 2024 was ₹5,138 Mil. Therefore, FDC's EBITDA margin for the quarter that ended in Sep. 2024 was 20.41%.


FDC EBITDA Margin % Historical Data

The historical data trend for FDC's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FDC EBITDA Margin % Chart

FDC Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.99 32.37 21.61 16.89 22.72

FDC Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.31 23.68 16.75 27.43 20.41

Competitive Comparison of FDC's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, FDC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FDC's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FDC's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where FDC's EBITDA Margin % falls into.



FDC EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

FDC's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=4396.764/19351.996
=22.72 %

FDC's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=1048.592/5138.487
=20.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FDC  (NSE:FDC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


FDC EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of FDC's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


FDC Business Description

Traded in Other Exchanges
Address
106 A, J. P. Road, C-3 Skyvistas, D.N. Nagar, Near Versova Police Station, Andheri (West), Mumbai, MH, IND, 400053
FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, Otek Ac Neo, Amodep AT, Simyl MCT Oil, and many others. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and other regions.